Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ZEN.V
STRONG SELLREMOVEZentek Ltd. · Healthcare · Canada · $50M · Avg Vol: $143K/d
Zentek is an early-stage nanomaterials and healthcare technology company. It lacks proven commercial scale, stable revenues, and a clear path to profitability, failing our strict quality filters.
COMPANY DESCRIPTION
Zentek Ltd. is an IP development and healthcare technology company focused on commercializing novel nanomaterials, including its proprietary ZenGuard™ antimicrobial coating. The company's competitive moat lies in its advanced materials research and its ability to apply graphene-based solutions to healthcare, environmental, and industrial challenges. Zentek operates as a high-margin technology incubator transitioning from research to commercial-scale manufacturing.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 0.2M | 51,417 | 21,042 | 0.6M | 37.0% |
| EPS | -0.24 | -0.10 | -0.08 | -0.07 | — |
| Shares | 99.2M | 99.5M | 100.8M | 104.4M | +5.2% |
| Debt | 1.6M | 1.1M | 0.9M | 0.5M | -32.7% |
| Equity | 29.3M | 21.4M | 14.2M | 10.4M | -29.2% |
| Op CF | -5.6M | -9.1M | -5.7M | -4.4M | — |
| Inv CF | -5.1M | -1.6M | 1.3M | 0.3M | — |
| Fin CF | 27.4M | -0.7M | -0.5M | 1.8M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ZEN.V are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ZEN.V | Zentek Ltd.(you) | $50M | 1 | STRONG SELL |
| QNTM.CN | Quantum BioPharma Ltd. | $45M | 2 | STRONG SELL |
| AIDR.CN | Rocket Doctor AI Inc. | $42M | 6 | STRONG SELL |
| MDNA.TO | Medicenna Therapeutics Corp. | $27M | 1 | STRONG SELL |
| BLO.CN | Cannabix Technologies Inc. | $58M | 11 | STRONG SELL |
| TLT.V | Theralase Technologies Inc. | $45M | 13 | STRONG SELL |
| OPTI.CN | Optimi Health Corp. | $25M | 2 | STRONG SELL |
| PINK.V | Perimeter Medical Imaging AI, Inc. | $30M | 9 | STRONG SELL |
| EDSA | Edesa Biotech, Inc. | $61M | 17 | STRONG SELL |
| MIST | Milestone Pharmaceuticals Inc. | $161M | 1 | STRONG SELL |
Peer medians: ROE -42.2% · P/E 14.3x · Gross margin 32.9%